Discovery of γ-Tetrahydrocarboline Derivatives as Plasmodium falciparum Histone Deacetylase Inhibitors for Treatment of Malaria
Journal of Medicinal Chemistry · 22.01.2026 · 69 (2) · 1434-1453
DOI: 10.1021/acs.jmedchem.5c02869 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 04.01.2026. Verfasst von Hao Ni und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. Hauptthemen laut MEDLINE: Plasmodium falciparum, Antimalarials, Histone Deacetylase Inhibitors, Carbolines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Program for Support of Top-notch Young Professionals, Youth Innovation Promotion Association of the Chinese Academy of Sciences, National Natural Science Foundation of China.
Abstract (Originalsprache)
Malaria is a life-threatening infectious disease caused by Plasmodium parasites, and the emergence of widespread resistance to existing therapies underscores the urgent need for novel antimalarial agents. Quisinostat was identified as a Plasmodium falciparum histone deacetylase 1 (PfHDAC1) inhibitor against drug-resistant malaria parasites but suffered from intolerable toxicity. To achieve a potent and safe antimalarial agent, we hypothesized a scaffold hopping and linker optimization strategy, in which a total of 33 new structural γ-tetrahydrocarboline derivatives were synthesized and subjected to comprehensive evaluation. Compound 5ac was identified as a PfHDAC1 inhibitor with favorable safety profiles (Pf3D7 IC50 = 4.1 nM, HepG2 IC50 = 1.5 μM, SI = 358; HEK293T IC50 = 15 μM, SI = 3573), improved physicochemical properties, and potent in vivo antimalarial activity. Mechanistic studies showed that 5ac could downregulate the expression of malaria invasion-related genes. Overall, this study establishes γ-tetrahydrocarboline derivatives as new structurally promising PfHDAC-targeted antimalarial agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 200031, China.
- School of Pharmaceutical Science, Hangzhou Medical College, Hangzhou 310053, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
- Institute of Molecular Sciences and Engineering, Institute of Frontier and Interdisciplinary Science, Shandong University, Qingdao 266237, China.
ORCID-Profile: Sunliang Cui
Förderung
- National Program for Support of Top-notch Young Professionals
- Youth Innovation Promotion Association of the Chinese Academy of Sciences
- National Natural Science Foundation of China
- Zhejiang Provincial Outstanding Youth Science Foundation
Zitieren
APA
Ni, H., Qian, Y., Dai, Z., Cai, Y., Cao, L., Li, J., Lai, Z., Hu, X., Huang, Z., Jiang, L., & Cui, S. (2026). Discovery of γ-Tetrahydrocarboline Derivatives as Plasmodium falciparum Histone Deacetylase Inhibitors for Treatment of Malaria. Journal of Medicinal Chemistry, 69(2), 1434-1453. https://doi.org/10.1021/acs.jmedchem.5c02869
Vancouver
Ni H, Qian Y, Dai Z, Cai Y, Cao L, Li J, et al. Discovery of γ-Tetrahydrocarboline Derivatives as Plasmodium falciparum Histone Deacetylase Inhibitors for Treatment of Malaria. Journal of Medicinal Chemistry. 2026;69(2):1434-1453. doi:10.1021/acs.jmedchem.5c02869
BibTeX
@article{Ni2026,
author = {Ni, Hao and Qian, Yunan and Dai, Zeguang and Cai, Yuan and Cao, Long and Li, Jiaming and Lai, Zhencheng and Hu, Xueping and Huang, Zhenghui and Jiang, Lubin and Cui, Sunliang},
title = {Discovery of γ-Tetrahydrocarboline Derivatives as Plasmodium falciparum Histone Deacetylase Inhibitors for Treatment of Malaria},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {2},
pages = {1434--1453},
doi = {10.1021/acs.jmedchem.5c02869}
}
EUVIMED